SCHEMBL1854630

SCHEMBL1854630

CC(C)(C)c1cc(CBr)ccc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.55
ALOX15 P16050 5/20 0.55
LMNA P02545 4/20 0.55
HTT P42858 2/20 0.55
CYP2C9 P11712 2/20 0.55
HSD17B10 Q99714 2/20 0.55
NR1I2 O75469 1/20 0.55
MIF P14174 1/20 0.55
TYR P14679 1/20 0.55
NFE2L2 Q16236 1/20 0.55
MAPT P10636 4/20 0.48
KDM4E B2RXH2 3/20 0.48
CYP1A2 P05177 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ATP2A2 P16615 1/20 0.48
ATP2A3 Q93084 1/20 0.48
TSHR P16473 4/20 0.44
GAA P10253 3/20 0.44
HSP90AA1 P07900 2/20 0.44
HSP90AB1 P08238 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31146612 0.83 ALDH1A1 (0.59) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL7199857 0.83 ALDH1A1 (0.59) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL2919862 0.83 ALDH1A1 (0.59) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL29836278 0.83 ALDH1A1 (0.59) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL27622698 0.82 ALOX15 (0.48) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL29603473 0.82 TRPA1 (0.59) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL245857 0.82 TRPA1 (0.59) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL5175624 0.82 ALDH1A1 (0.57) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL3408135 0.81 ALDH1A1 (0.70) ALDH1A1ALOX15LMNAHTTCYP2C9
SCHEMBL29572639 0.81 ALDH1A1 (0.70) ALDH1A1ALOX15LMNAHTTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4463187-A Process for the preparation of 3,5-dihydrocarbyl-4-hydroxybenzylmalonic acid esters ETHYL CORPORATION (US) 1984-07-31 US claimed
US-8673890-B2 2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist JANSSEN PHARMACEUTICA NV (BE) 2014-03-18 US disclosed
US-20110105490-A1 2,3-DIHYDRO-1H-ISOINDOL-1-IMINE DERIVATIVES USEFUL AS THROMBIN PAR-1 RECEPTOR ANTAGONIST JANSSEN PHARMACEUTICA NV (BE) 2011-05-05 US disclosed
EP-0163635-A4 PROCESS FOR PREPARING SUBSTITUTED BENZYL MALONIC ACID ESTERS. ETHYL CORP (US) 1986-04-02 EP disclosed
EP-0163635-A1 PROCESS FOR PREPARING SUBSTITUTED BENZYL MALONIC ACID ESTERS ETHYL CORPORATION (US) 1985-12-11 EP disclosed
WO-1985002182-A1 PROCESS FOR PREPARING SUBSTITUTED BENZYL MALONIC ACID ESTERS ETHYL CORPORATION (US) 1985-05-23 WO disclosed
US-4463187-A Process for the preparation of 3,5-dihydrocarbyl-4-hydroxybenzylmalonic acid esters ETHYL CORPORATION (US) 1984-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105490-A1 2,3-DIHYDRO-1H-ISOINDOL-1-IMINE DERIVATIVES USEFUL AS THROMBIN PAR-1 RECEPTOR ANTAGONIST F2R, F2RL1, F2RL3 ALDH1A1 1921/4885ALOX15 847/4885LMNA 1425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.